ALSAF Safe Orthopaedics

Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore

Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore

 



 



Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore



 



 



  • 11,500 surgeries performed in France
  • Success of the evaluation phase of the new vertebral compression fracture (VCF) treatment, Sycamore
 



 
   

Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, November 25, 2021 at 5:45 pm CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for emergency-treated vertebral fractures, announces the

20,000th kit sold, and the success of the evaluation phase of Sycamore, the novel vertebral compression fracture (VCF) treatment.

Firstly, Safe Orthopaedics has successfully reached the significant mark of 20,000 instrument kits sold across the globe. With this achievement many patients have been successfully treated using Safe Orthopaedics’ proprietary ready-to-use technology that delivers significant benefits to the hospital, the surgical team, and the patient.

On this topic, Nik Beyer, Chief Commercial Officer of Safe Orthopaedics says: “Despite significant market headwinds I’m delighted that through the hard work and determination of our direct sales teams, distribution partners and support teams we have continued to prove that there is a real, and growing, un-met need for our ready-to-use technology in the global spine market.”

Secondly, through close collaboration with surgeons in France and Germany, Safe Orthopaedics is coming to the end of a successful evaluation phase for its novel vertebral compression fracture (VCF) treatment, Sycamore.  With the completion of this phase Sycamore is ready for launch early 2022 in select markets.

Nik Beyer comments: “Sycamore is an exciting product for our portfolio, a new concept to the market that promises to deliver significant growth through 2022 and beyond in a VCF market that continues to show year-on-year growth.  Market trends showed us that the solutions available to surgeons to manage these hard-to-treat patients do not always achieve the best results, Sycamore is designed to meet those demands”.



Pierre Dumouchel, CEO & Chairman of Safe Group concludes: “It’s with great pride that we make this announcement today. Our focus has always been on delivering the best possible outcome for patients and it’s a privilege to have contributed to the optimal treatment of so many patients.  To deliver this milestone in tough market conditions, during a pandemic, and follow-up with a major piece of product development in Sycamore is testament to the investment we have made in both our commercial and innovation business units and the close working partnerships we have with our expert surgeons.  For VCF patients, a long-term correction of the fracture is key to delivering the best patient outcome.  Our Sycamore implant is designed to deliver exactly that”.

About Safe Group

Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs approximately 150 people.

Safe Orthopaedics develops and manufactures kits combining sterile implants and single-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risk of contamination and infection, for the benefit of the patient and with a positive impact on hospitalization times and costs.  Protected by 18 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopaedics is headquartered in the Paris region (Eragny-sur-Oise (95610)) and has subsidiaries in the United Kingdom, Germany, the United States and the Lyon region (Fleurieux-sur-l'Arbresle).

For more information:

Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation centre and two production sites in France (Fleurieux-sur-l'Arbresle, 69210) and Tunisia, offering a wide range of industrial services: design, industrialisation, machining, finishing and sterile packaging. Supported by the French recovery plan in 2020, the company invests in additive printing and will be operational in 2022 on this new technology.

For more information:

Contacts 

Safe Orthopaedics                                                                                    

François-Henri Reynaud                  

Chief Financial and Administrative Officer                    

Tél. : +33 (0)1 34 21 50 00                              

           

Press Relations

Ulysse Communication

Pierre-Louis Germain / +33 (0)6 64 79 97 51 /

Bruno Arabian / +33 (0)6 87 88 47 26 /

Attachment



EN
25/11/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Safe Orthopaedics

 PRESS RELEASE

Safe Orthopaedics annonce la vente du 20 000e kit et le succès de la p...

Safe Orthopaedics annonce la vente du 20 000e kit et le succès de la phase d’évaluation de Sycamore     Safe Orthopaedics annonce la vente du 20 000e kit et le succès de la phase d’évaluation de Sycamore     11 500 interventions chirurgicales réalisées en FranceSuccès de la phase d'évaluation du nouveau traitement de la fracture par compression vertébrale (VCF), Sycamore           Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, le 25 novembre 2021 à 17h45 CET - Safe Orthopaedics (FR0013467123 - ALSAF), société spécialisée dans la conception, la fabrication et la...

 PRESS RELEASE

Safe Orthopaedics announces the 20,000th kit sold and the success of t...

Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore   Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore   11,500 surgeries performed in FranceSuccess of the evaluation phase of the new vertebral compression fracture (VCF) treatment, Sycamore       Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, November 25, 2021 at 5:45 pm CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly sa...

 PRESS RELEASE

Safe Orthopaedics announces first SORA-assisted surgeries and producti...

Safe Orthopaedics announces first SORA-assisted surgeries and production of two new units   Safe Orthopaedics announces first SORA-assisted surgeries and production of two new units   First surgeries performed with the SORA surgical assistant in the first French evaluation center and the support of Doctor Pierre VallèseTwo new SORA units produced for installation in France and GermanyInterview with Dr. Pierre Vallèse, orthopaedic and trauma surgeon at the Convert Clinic in Bourg-en-Bresse       Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, October 13, 2021 at 5:45 pm CET - Safe Orthopaedics (F...

 PRESS RELEASE

Safe Orthopaedics annonce les premières chirurgies effectuées sous ass...

Safe Orthopaedics annonce les premières chirurgies effectuées sous assistance SORA ainsi que la production de deux nouvelles unités                                                                                                                                                    Safe Orthopaedics annonce les premières chirurgies effectuées sous assistance SORA ainsi que la production de deux nouvelles unités   Premières chirurgies effectuées avec l’assistant de chirurgie SORA dans le premier centre d’évaluation français et le support du Docteur Pierre VallèseDeux nouvelles unités SORA produ...

 PRESS RELEASE

Safe Medical inaugure son Centre d’Innovation et de Production Intégré...

Safe Medical inaugure son Centre d’Innovation et de Production Intégré (CIPI) sur le site industriel de Fleurieux-sur-l’Arbresle (69)                                                                                                                                                     Safe Medical inaugure son Centre d’Innovation et de Production Intégré (CIPI) sur le site industriel de Fleurieux-sur-l’Arbresle (69)   Un module d’impression 3D titane et une salle blanche dédiée au conditionnement complètent les installations existantes2,5M€ ont été investis sur le site de Safe Medical...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch